<SEC-DOCUMENT>0001493152-20-019301.txt : 20201013
<SEC-HEADER>0001493152-20-019301.hdr.sgml : 20201013
<ACCEPTANCE-DATETIME>20201013093037
ACCESSION NUMBER:		0001493152-20-019301
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20201006
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20201013
DATE AS OF CHANGE:		20201013

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Processa Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001533743
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				451539785
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39531
		FILM NUMBER:		201234963

	BUSINESS ADDRESS:	
		STREET 1:		7380 COCA COLA DRIVE
		STREET 2:		SUITE 106
		CITY:			HANOVER
		STATE:			MD
		ZIP:			21076
		BUSINESS PHONE:		443-776-3133

	MAIL ADDRESS:	
		STREET 1:		7380 COCA COLA DRIVE
		STREET 2:		SUITE 106
		CITY:			HANOVER
		STATE:			MD
		ZIP:			21076

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Heatwurx, Inc.
		DATE OF NAME CHANGE:	20111028
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>UNITED
STATES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>WASHINGTON,
D.C. 20549</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0 auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>FORM
8-K</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0 auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CURRENT
REPORT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pursuant
to Section 13 or 15(d) of the</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Securities
Exchange Act of 1934</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date
of Report (Date of earliest event reported): October 6, 2020</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0 auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>PROCESSA
PHARMACEUTICALS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Exact
Name of Registrant as Specified in its Charter)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0 auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Delaware</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; width: 2%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>001-39531</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; width: 2%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>45-1539785</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(State
    or Other Jurisdiction <BR>
    of Incorporation)</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Commission<BR>
    File Number)</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(IRS
    Employer<BR>
    Identification No.)</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 34%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7380
    Coca Cola Drive, Suite 106, Hanover, Maryland </B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>21076</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Address
    of Principal Executive Offices)</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Zip
    Code)</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Registrant&rsquo;s
telephone number, including area code: (443) 776-3133</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Not
Applicable</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Former
Name or Former Address, if Changed Since Last Report)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0 auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
    communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0 auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: bottom; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 38%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of each class</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; width: 2%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 19%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading
    Symbol(s)</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; width: 2%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 39%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of each exchange on which registered</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    Stock, $0.0001 par value per share</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PCSA</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Nasdaq Stock Market LLC </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&sect;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&sect;240.12b-2 of this chapter).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company [&nbsp;&nbsp;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 4.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [&nbsp;&nbsp;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; border-bottom: Black 4pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.65in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
    5.02 </B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Departure
of Directors or Certain Officers; Election of Director; Appointment of Certain officers; Compensatory Arrangements of Certain
Officers.</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 6, 2020, Dr. David Young, President and CEO of Processa Pharmaceuticals, Inc. (the &ldquo;Company&rdquo; or &ldquo;Processa&rdquo;)
appointed R. Michael Floyd, age 64, as Chief Operating Officer of the Company and entered into an employment agreement (the &ldquo;Agreement&rdquo;)
between the Company and Mr. Floyd, governing the terms of Mr. Floyd&rsquo;s employment, which became effective October 1, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Floyd has been a serial entrepreneur with over 15 years&rsquo; experience with early stage biopharma businesses in infectious
diseases, oncology and rare diseases. In 1996 he founded Neurologic, an early stage enterprise that in-licensed technology from
the National Institutes of Health for a diagnostic test for Alzheimer&rsquo;s disease. Mr. Floyd was the co-author of the plan
that created the Blanchette Rockefeller Neurosciences Institute in 1998 with the Honorable Jay Rockefeller and Johns Hopkins University.
Mr. Floyd was the chief executive officer for the North American subsidiary of Arpida Ltd. from 2006 where he organized the phase
3 program for an MRSA drug and oversaw the NDA submission. Mr. Floyd led the US efforts to remediate the NDA for Gentium, SpA
for defibrotide from 2011. Mr. Floyd was a founder of Bio-AIM, which is developing monoclonal antibodies for Acinetobacter baumannii
and Exbaq which is developing therapies for Gram negative pathogens. In 2016, Mr. Floyd co-founded Elion Oncology and has served
as its Chief Executive officer until joining Processa. Mr. Floyd received a BSBA in accounting from Georgetown University and
is a CPA (inactive).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Agreement, Mr. Floyd will receive an annual base salary of $87,500. The Company granted Mr. Floyd 50,000 Restricted Stock
Units of the Company&rsquo;s common stock. The RSUs will vest over 4-years at 25% each year. In the event Mr. Floyd is terminated
without Cause (as defined in the Agreement), or for Good Reason (as defined in the Agreement) the Company is required to provide,
in writing 52 weeks&rsquo; notice The RSUs shall fully vest upon Change in Control (as defined in the Agreement) of if Mr. Floyd
is terminated without Cause or for Good Reason. He may also receive a severance payment at Processa&rsquo;s discretion. Mr. Floyd
is entitled to participate in all employee benefits available to employees of the Company. The Employment Agreement also includes
confidentiality provisions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
press release announcing Mr. Floyd&rsquo;s employment is filed as Exhibit 99.1 hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing summary of the Agreement is qualified in its entirety by the copy of such agreement filed as Exhibit 10.1 hereto and
incorporated herein by this reference.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; width: 0.65in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item 9.01.</B></FONT></TD>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Financial Statements and Exhibits.</B></FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -1in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 0.65in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit<BR>
No.</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.1in; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Description</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ex10-1.htm">Employment
    Agreement, dated October 6, 2020, between Processa Pharmaceuticals and R. Michael Floyd</A></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><A HREF="ex99-1.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press
    Release issued on October 13, 2020</FONT></A></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SIGNATURES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROCESSA
    PHARMACEUTICALS, INC.</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 50%; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 3%; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 47%; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    October 13, 2020</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    David Young</I></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">David
    Young</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ex10-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PROCESSA
PHARMACEUTICALS INC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EMPLOYMENT
AGREEMENT</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">October
1, 2020</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Employment Agreement is entered into as of the date of the last signature affixed hereto, by and between Processa Pharmaceuticals
Inc., a Delaware corporation (&ldquo;Processa&rdquo;), and R. Michael Floyd, (&ldquo;Employee&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
consideration of the mutual promises and covenants set forth herein, and other good and valuable consideration, the sufficiency
of which is hereby acknowledged, Processa and Employee hereby agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Position
    of Employment. Processa will employ the Employee in the position of Chief Operations Officer (COO) and, as COO, Employee will
    report to the CEO. Processa retains the right to change Employee&rsquo;s title, duties, and reporting relationships as may
    be determined to be in the best interests of Processa; provided, however, that any such change in Employee&rsquo;s duties
    shall be consistent with Employee&rsquo;s training, experience, and qualifications.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    terms and conditions of the Employee&rsquo;s employment shall, to the extent not addressed or described in this Employment
    Agreement, be governed by Processa&rsquo;s Policies and Procedures Manual and existing practices. In the event of a conflict
    between this Employment Agreement and the Policies and Procedures Manual or existing practices, the terms of this Agreement
    shall govern.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Term
    of Employment. Employee&rsquo;s employment with Processa shall begin on October 1, 2020. This agreement will remain in effect
    for 3 years, after which time the agreement will renew annually, after which time continued employment shall be on an &ldquo;at
    will&rdquo; basis, unless:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employee&rsquo;s
    employment is terminated by either party in accordance with the terms of Section 5 of this Employment Agreement; or</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Such
    term of employment is extended or shortened by a subsequent agreement duly executed by each of the parties to this Employment
    Agreement, in which case such employment shall be subject to the terms and conditions contained in the subsequent written
    agreement.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --> |
                                                                                                                                                                                                                               Page</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compensation
    and Benefits.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Base
    Salary. Employee shall receive an annual base salary of $87,500, for a full-time effort, commensurate with other C-Suite Executives
    in Processa, other than the CEO. Any increases in Employee&rsquo;s Base Salary for years beyond December 31, 2020 shall be
    at the sole discretion of the Processa Board of Directors, and nothing herein shall be deemed to require any such increase.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock
    Options and Restricted Stock Units. Subject to approval by the Processa&rsquo;s Board of Directors (the &ldquo;Board&rdquo;),
    and pursuant to the Processa&rsquo;s 2017 Stock Plan (the &ldquo;Plan&rdquo;), Processa may grant Employee an option to purchase
    shares of Processa&rsquo;s common stock at the fair market value as determined by the Board as of the date of grant (the &ldquo;Option&rdquo;)
    and commensurate with other C-Suite Executives in Processa, other than the CEO. The specifics of the stock options will be
    described in the Stock Option Agreement and Stock Option Award provided to the Employee. Processa may also grant Employee
    Restricted Stock Units of Processa&rsquo;s common stock commensurate with other C-Suite Executives in Processa, other than
    the CEO. The specifics of the Restricted Stock Units will be described in the Restricted Stock Unit Agreement and Restricted
    Stock Unit Award provided to the Employee.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incentive
    and Deferred Compensation. Employee shall be eligible to participate in all incentive and deferred compensation programs available
    to other executives or officers of Processa, such participation to be in the same form, under the same terms, and to the same
    extent that such programs are made available to other such executives or officers. Nothing in this Employment Agreement shall
    be deemed to require the payment of bonuses, awards, or incentive compensation to Employee if such payment would not otherwise
    be required under the terms of Processa&rsquo;s incentive compensation programs.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employee
    Benefits. Employee shall be eligible to participate in all employee benefit plans, policies, programs, or perquisites in which
    other Processa executive or officers participate, including the Processa Stock Option program. The terms and conditions of
    Employee&rsquo;s participation in Processa&rsquo;s employee benefit plans, policies, programs, or perquisites shall be governed
    by the terms of each such plan, policy, or program.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Duties
    and Performance. The Employee acknowledges and agrees that he is being offered a position of employment by the Processa with
    the understanding that the Employee possesses a unique set of skills, abilities, and experiences which will benefit Processa,
    and he agrees that his continued employment with Processa, whether during the term of this Employment Agreement or thereafter,
    is contingent upon his successful performance of his duties in his position as noted above, or in such other position to which
    he may be assigned.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --> |
                                                                                                                                                                                                                               Page</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
    Duties.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employee
    shall render to the very best of Employee&rsquo;s ability, on behalf of the Processa, services to and on behalf of the Processa,
    and shall undertake diligently all duties assigned to him by the Processa.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employee
    shall devote his full time, energy and skill to the performance of the services in which Processa is engaged, at such time
    and place as Processa may direct. Employee shall not undertake, either as an owner, director, shareholder, employee or otherwise,
    the performance of services for compensation (actual or expected) for any other entity without the express written consent
    of the Board of Directors.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employee
    shall faithfully and industriously assume and perform with skill, care, diligence and attention all responsibilities and duties
    connected with his employment on behalf of Processa.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employee
    shall have no authority to enter into any contracts binding upon Processa, or to deliberately create any obligations on the
    part of Processa, except as may be specifically authorized by the Board of Directors of Processa.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Specific
    Duties. </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Plans,
    coordinates, and oversees all aspects of investor relations, related meetings, and public relations.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assists
    the CEO with general operations of the Company.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    duties as assigned.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Termination
    of Employment. Employee&rsquo;s employment with Processa may be terminated, prior to the expiration of the term of this Employment
    Agreement, in accordance with any of the following provisions:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Termination
    by Employee. The Employee may terminate his employment at any time during the course of this agreement by giving 8 weeks&rsquo;
    notice in writing to the Board of Directors of Processa. During the notice period, Employee must fulfill all his duties and
    responsibilities set forth above and use his best efforts to train and support his replacement, if any. Failure to comply
    with this requirement may result in Termination for Cause described below, but otherwise Employee&rsquo;s salary and benefits
    will remain unchanged during the notification period.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --> |
                                                                                                                                                                                                                               Page</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Termination
    by Employee for Good Reason. The Employee may terminate employment with the Company for Good Reason. &ldquo;Good Reason&rdquo;
    shall mean the occurrence without Employee&rsquo;s written consent, of one or more of the following events: (i) the Company
    reduces Employee&rsquo;s base salary to a salary not typical of the other C-Suite Executives in Processa, other than the CEO,
    (ii) the Company materially decreases Employee&rsquo;s responsibilities, (iii) the Company relocates Employee&rsquo;s principal
    place of work to a location more than fifty (50) miles from the location of Employee&rsquo;s principal place of work on the
    date of this Agreement, or (iv) the Company materially breaches the terms of this Agreement; provided that no such event shall
    constitute Good Reason hereunder unless (a) Employee shall have given written notice to the Company of Employee&rsquo;s intent
    to resign for Good Reason within 30 days after Employee becomes aware of the occurrence of any such event (specifying in detail
    the nature and scope of the event), (b) such event or occurrence shall not have been cured within 30 days of the Company&rsquo;s
    receipt of such notice, (c) any Termination by Employee for Good Reason following such 30 day cure period must occur no later
    than the date that is 30 days following the expiration of such 30 day cure period. Employee&rsquo;s Termination for Good Reason
    shall be treated as involuntary.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Termination
    by Processa Without Cause. Processa may terminate Employee&rsquo;s employment at any time during this agreement by giving
    fifty-two (52) weeks&rsquo; notice in writing to the Employee. During the notice period, Employee must fulfill all of Employee&rsquo;s
    duties and responsibilities set forth above and use Employee&rsquo;s best efforts to train and support Employee&rsquo;s replacement,
    if any. Failure of Employee to comply with this requirement may result in Termination for Cause described below, but otherwise
    Employee&rsquo;s salary and benefits will remain unchanged during the notification period. Processa, may, in its sole discretion,
    give Employee severance pay in the amount of the remaining notice period in lieu of actual employment, and nothing herein
    shall require Processa to maintain employee in active employment for the duration of the notice period.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Termination
    by Processa For Cause. Processa may, at any time and without notice, terminate the Employee for &ldquo;cause&rdquo;. Termination
    by Processa of the Employee for &ldquo;cause&rdquo; shall include but not be limited to termination based on any of the following
    grounds: (a) failure to perform the duties of the Employee&rsquo;s position in a satisfactory manner; (b) fraud, misappropriation,
    embezzlement or acts of similar dishonesty; (c) conviction of a felony involving moral turpitude; (d) illegal use of drugs
    or excessive use of alcohol in the workplace; (e) intentional and willful misconduct that may subject Processa to criminal
    or civil liability; (f) breach of the Employee&rsquo;s duty of loyalty, including the diversion or usurpation of corporate
    opportunities properly belonging to Processa; (g) willful disregard of Processa policies and procedures; and (h) breach of
    any of the material terms of this Agreement.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --> |
                                                                                                                                                                                                                               Page</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Termination
    By Death or Disability. The Employee&rsquo;s employment and rights to compensation under this Employment Agreement shall terminate
    if the Employee is unable to perform the duties of his position due to death or disability lasting more than 90 days, and
    the Employee&rsquo;s heirs, beneficiaries, successors, or assigns shall not be entitled to any of the compensation or benefits
    to which Employee is entitled under this Agreement, except: (a) to the extent specifically provided in this Employment Agreement
    (b) to the extent required by law; or (c) to the extent that such benefit plans or policies under which Employee is covered
    provide a benefit to the Employee&rsquo;s heirs, beneficiaries, successors, or assigns.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Termination
    of Employment for Good Reason Involving a Change of Control. Employee&rsquo;s employment with Processa may be terminated in
    the event that a Change in Control occurs which is also a Cash Severance Change in Control (as defined below), and Employee&rsquo;s
    employment with the Company is terminated by the Company Without Cause at any time within the three (3) month period before
    the date of such Cash Severance Change in Control or during the fifty-two (52) week period following the date of such Cash
    Severance Change in Control, Employee will receive severance as stated in Section 5.c.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    purposes of this Section, &ldquo;<B>Cash Severance Change in Control</B>&rdquo; shall mean and include:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acquisition
    by any &ldquo;Person&rdquo; or &ldquo;Group&rdquo; of securities entitled to vote generally in the election of directors (&ldquo;voting
    securities&rdquo;) of the Company that represent 50% or more of the combined voting power of the Company&rsquo;s then outstanding
    voting securities;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Merger
    or consolidation in which the seller&rsquo;s shareholders no longer control the surviving entity;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sale
    of substantially all assets to an unrelated entity.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Confidentiality.
    Employee agrees that at all times during Employee&rsquo;s employment and following the conclusion of Employee&rsquo;s employment,
    whether voluntary or involuntary, Employee will hold in strictest confidence and not disclose Confidential Information (as
    defined below) to anyone who is not also an employee of Processa or to any employee of Processa.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Confidential
    Information&rdquo; shall mean any trade secrets or Processa proprietary information, including but not limited to manufacturing
    techniques, processes, formulas, customer lists, inventions, experimental developments, research projects, operating methods,
    cost, pricing, financial data, business plans and proposals, data and information Processa receives in confidence from any
    other party, or any other secret or confidential matters of Processa. Additionally, Employee will not use any Confidential
    Information for Employee&rsquo;s own benefit or to the detriment of Processa during Employee&rsquo;s employment or thereafter.
    Employee also certifies that employment with Processa does not and will not breach any agreement or duty that Employee has
    to anyone concerning confidential information belonging to others.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --> |
                                                                                                                                                                                                                               Page</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expenses.
    Processa shall pay or reimburse Employee for any expenses reasonably incurred by him in furtherance of his duties hereunder,
    including expenses for entertainment, travel, meals and hotel accommodations, upon submission by him of vouchers or receipts
    maintained and provided to Processa in compliance with such rules and policies relating thereto as Processa may from time
    to time adopt.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
    Provisions.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notices.
    All notices and other communications required or permitted by this Agreement to be delivered by Processa or Employee to the
    other party shall be delivered in writing to the address shown below, either personally, by facsimile transmission or by registered,
    certified or express mail, return receipt requested, postage prepaid, to the address for such party specified below or to
    such other address as the party may from time to time advise the other party, and shall be deemed given and received as of
    actual personal delivery, on the first business day after the date of delivery shown on any such facsimile transmission or
    upon the date or actual receipt shown on any return receipt if registered, certified or express mail is used, as the case
    may be.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0; margin-right: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 1in; font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0; margin-right: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Processa
Pharmaceuticals, Inc.:</FONT></P>

<P STYLE="text-indent: 1.5in; font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0; margin-right: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 1.5in; text-align: left; margin-top: 0; margin-right: 0; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Processa Pharmaceuticals, Inc.</FONT></P>

<P STYLE="text-indent: 1.5in; font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0; margin-right: 0; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">7380 Coca Cola Drive</FONT></P>

<P STYLE="text-indent: 1.5in; font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0; margin-right: 0; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Suite 106</FONT></P>

<P STYLE="text-indent: 1.5in; font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0; margin-right: 0; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Hanover, MD 21076</FONT></P>

<P STYLE="text-indent: 1.5in; font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0; margin-right: 0; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Attn: Wendy Guy</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0; margin-right: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-indent: 1in; font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0; margin-right: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employee:</FONT></P>

<P STYLE="text-indent: 1.5in; font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0; margin-right: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 1.5in; text-align: left; margin-top: 0; margin-right: 0; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Robert Michael Floyd</FONT></P>

<P STYLE="text-indent: 1.5in; font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0; margin-right: 0; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">5817 Ogden Court</FONT></P>

<P STYLE="text-indent: 1.5in; font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0; margin-right: 0; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Bethesda, MD 20816</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0; margin-right: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendments
    and Termination; Entire Agreement. This Agreement may not be amended or terminated except by a writing executed by all of
    the parties hereto. This Agreement constitutes the entire agreement of Processa and Employee relating to the subject matter
    hereof and supersedes all prior oral and written understandings and agreements relating to such subject matter.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Successors
    and Assigns. The rights and obligations of the parties hereunder are not assignable to another person without prior written
    consent; provided, however, that Processa, without obtaining Employee&rsquo;s consent, may assign its rights and obligations
    hereunder to a wholly-owned subsidiary and provided further that any post-employment restrictions shall be assignable by Processa
    to any entity which purchases all or substantially all of Processa&rsquo;s assets.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --> |
                                                                                                                                                                                                                               Page</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Severability;
    Provisions Subject to Applicable Law. All provisions of this Agreement shall be applicable only to the extent that they do
    not violate any applicable law and are intended to be limited to the extent necessary so that they will not render this Agreement
    invalid, illegal or unenforceable under any applicable law. If any provision of this Agreement or any application thereof
    shall be held to be invalid, illegal or unenforceable, the validity, legality and enforceability of other provisions of this
    Agreement or of any other application of such provision shall in no way be affected thereby.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Waiver
    of Rights. No waiver by Processa or Employee of a right or remedy hereunder shall be deemed to be a waiver of any other right
    or remedy or of any subsequent right or remedy of the same kind.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definitions;
    Headings; and Number. A term defined in any part of this Employment Agreement shall have the defined meaning wherever such
    term is used herein. The headings contained in this Agreement are for reference purposes only and shall not affect in any
    manner the meaning or interpretation of this Employment Agreement. Where appropriate to the context of this Agreement, use
    of the singular shall be deemed also to refer to the plural, and use of the plural to the singular.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Counterparts.
    This Agreement may be executed in separate counterparts, each of which shall be deemed an original but both of which taken
    together shall constitute but one and the same instrument.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Governing
    Laws and Forum. This Agreement shall be governed by, construed, and enforced in accordance with the laws of Maryland. The
    parties hereto further agree that any action brought to enforce any right or obligation under this Agreement shall be subject
    to the exclusive jurisdiction of the courts of Maryland.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --> |
                                                                                                                                                                                                                               Page</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><IMG SRC="ex10-1_001.jpg" ALT="" STYLE="height: 881; width: 680"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --> | Page</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>ex99-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
    IMMEDIATE RELEASE</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    More Information:</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
    Floyd</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>mfloyd@processapharma.com</U></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Processa
Pharmaceuticals Announces Appointment of Michael Floyd as Chief Operating Officer</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">HANOVER,
Md. &ndash; Oct. 13, 2020 &ndash; Processa Pharmaceuticals, Inc. (NASDAQ: PCSA) (&ldquo;Processa&rdquo; or the &ldquo;Company&rdquo;),
<FONT STYLE="background-color: #FEFEFE">a clinical-stage biopharmaceutical company developing products to improve survival and/or
quality of life for patients who have high unmet medical needs, is pleased to announce the appointment of Michael Floyd as the
Company&rsquo;s Chief Operating Officer.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Floyd is a serial entrepreneur who, over the last 15 years, has formed and been a senior executive in several life science organizations
focused on the development of products to treat infectious and rare diseases, as well as the development of oncology drugs. He
founded the early stage enterprise Neurologic, that in-licensed technology from the NIH for a diagnostic test for Alzheimer&rsquo;s
disease. In 2006 he served as the CEO for the North American subsidiary of Arpida Ltd. and organized the phase 3 program for the
NDA submission of an MRSA drug. Then after joining Gentium, SpA in 2011, he led the US efforts to remediate the NDA for defibrotide.
More recently, Mr. Floyd co-founded Elion Oncology which licensed PCS6422 to Processa.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: #FEFEFE">&ldquo;Adding
Mike to our leadership team will enable me to spend more time focusing on our long-term strategic direction and our pipeline,&rdquo;
said Dr. David Young, CEO and Chairman of Processa. &ldquo;Mike is a proven life science entrepreneur with a demonstrated track
record of successfully delivering results. He has the leadership capabilities we are looking for to help us grow Processa. In
addition to assisting me in overseeing operations, Mike will manage our public relations program and work with Patrick Lin, our
Chief Business- Strategy Officer, to ensure that our existing investors and potential investors are informed as the Processa drugs
hit their key milestones over the next 12-18 months.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&ldquo;I
am excited and delighted to join the Processa team and to leverage the company&rsquo;s incredibly talented development team to
efficiently bring important, life-changing therapies to patients with underserved, serious indications,&rdquo; Mr. Floyd said.
&ldquo;As the founder of Elion, I greatly resonated with the manner in which the Processa team operates, and I have the greatest
confidence in their disciplined approach to highly efficient pharmaceutical development. I appreciate how Processa developed a
pipeline of de-risked drugs while planning to efficiently and safely attack high-value milestones. Elion sought out a collaborative
engagement with the very best development partners and we found that partner in Processa. Our oncology drug 6422 is in great hands
with Processa given their experience with this class of oncology therapy, their experience in oncology drug development, the Regulatory
Science approach they use to develop drugs, and their overall corporate approach to efficiently run and manage Processa.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
Processa Pharmaceuticals, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
mission of Processa has been to develop products for which existing clinical evidence of efficacy already exists in unmet medical
need conditions &ndash; medical conditions for which patients need treatment options that will improve survival and/or quality
of life. The Company has assembled a proven regulatory science development team, management team and board of directors. The members
of the Processa development team have been involved with more than 30 drug approvals by the FDA (including drug products targeted
to orphan disease conditions) and 100 FDA meetings throughout their careers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Forward-Looking
Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
release contains forward-looking statements. The statements in this press release that are not purely historical are forward-looking
statements which involve risks and uncertainties. Actual future performance outcomes and results may differ materially from those
expressed in forward-looking statements. Please refer to the documents filed by Processa Pharmaceuticals with the SEC, specifically
the most recent reports on Forms 10-K and 10-Q, which identify important risk factors which could cause actual results to differ
from those contained in the forward-looking statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">#</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>ex10-1_001.jpg
<TEXT>
begin 644 ex10-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 2Y Z4# 2(  A$! Q$!_\0
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M-(!CK0?KB@ [<XSZ4O!.#FFX]^E+Q_D4 +^M! [4O'K2=Z #'-)P.]'3K2T
M!Z4ASQUHQZ\TM #2>@[TN[BCMC)I,<=2* $S@TO0\BD XZ]*=GG^M !GVI 2
M!THX]:4>F* %!XHI  *,T  SW% )HR/2@$'I0 9&:6@=** %^4<T'!YH!]C2
M]30 #M2T?RI,<YH .F:,$#UH/?BCG&,T ,A/RD?[3?SJ2F0CY&XZLW\S3^ .
MGXT %(1FE/'O28YS0 F,4'DXI?PI,>] %.]&3;8(_P!>O]:M]JJ7X^:VP?\
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M;C\?K2F@8SGO0 8I,8ZT[@TA% "9X(]:!Z44IQ^% "=/H*.0,Y_2EX^M(,4
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MD[>] )/6@ ..F:6CCTYH(SQ0 F,\THR*3'J<TIYH 3H:3 ]:7.#C^5(!DYH
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M^6R_UJUGCZ55OOO6PQ_RW6K8]>@H *0D8^M+CTH^HH  /PH!QVI01[TN0>E
M"XS1WY -)^M*,T +US28(H/49I>W%  ,=:BE WQ?[W]#4O-12<O%G^]_0TT)
MC^<<T#D9IRX]>:#]*0Q.G6C@TON*0<G_  H %'H*7!%(1@4@H ,<]*7O100,
M4 &.W2D[>]'XT$>M !@^U+[=:3OD4O7F@ _E0/K2'@]Z,CI^E "CWI.<^U+2
M9'2@ _BH[44O.?6@ QWI./:E/%(>:  C=1@#ZT=LBCK0 A I0?3I1SG/:E&/
M2@!,"E_&BCO0 F/RI>@Q0>G% S0 F/>EV_A1^6/K2@?E0 W %.QP10>OO1GF
M@!!@=NE'7G-!;!]<TN: #% I?6D'3O0 9!.*!@44$XH 4\C%-..PIQQ2#\*
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MY% "Y!H/^<4#!%& 3[T * ">F*4CG@T@_6CKZ_A0  CFCI2GITI1T_\ KT
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M%&>O2@#U-I%1&=F 4#))X %<=J'CZQG\'7VM:'<VTL]M&\@@G(+$(^TY4-D
MXX/N*G\ 2)=_#S1ED=9Q]D6-]V&&!P5/\J\^M+S1[?X3ZYIAFLX]7@6[CE@)
M59U'G' 8=<<KC\!0!ZSI6L0:C:0_OX/M9@266!'!:/<H/(SD#)[U#H^N/?6U
M[<7EO;VD%O<O%%*EVDJ2Q#&V0E>%S_=/(KA=-@TG3?$W@22R^S07-UILZS&,
M@/-F)&!;'+9;<>>^:R[5-,U'PQKUJ^LV^GLWBN9[:5E#Q&3=NB5@.-C;>_'
M^A /7K2_M+]#)9W,,Z X+12!Q^AI)K^SM[B.VFNH(IY/N1O( S?0'DURG@34
M8]0DUEFTVTMKZ&Z$5Y<V+%K>ZE"@;D/L,9';C))-<M/]DDTCXBKX@$/]I-<2
MB,2@%S#L_P!%V#KC.-N.^>] '9^(O%,MAKEEHE@;1;ZYADF\R\8B- H^53@@
MY9L#VY//2H-#\3ZEKFJ/##_9@@M;EK6[C\UC*2B#=)'VV^8=HR.G.>PYBQC>
M3QMX-CUI8Y-1;17%PDX#2&3"D;L\[N&Y]0?>J.HJB> O'EQI$4!N8]4N(S)
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M@]>H)KF=5M;J]^*]O#:ZA-8O_8;L98(XW8CSQQAU88S[=JXZWO;BR\&W>GQ
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M23V-M*D./*62)6"?[N1Q^%6\C(I: .9UOP[-JOB31[UDLI;&R2998+@$F3S
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M]-Y$ "$[GVEL<#C@'DT 8GB7P_!<:-+:Z;9V,%U<1M:QR-$%"*RD=57.!DG
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MQM9K,  020JT8 Z84C'':HCH6D'3/[-.EV)L/^?7[.GE?]\8Q^E:&!2?C^5
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M5YK^'6%EAF:2&%6B=4#"2/8@XR3PVX5E:?K_ (AN+--$FUFY'B :R]I)*MO
M-MNH#M(4\O&WR^A_O,.3TKK8/#-KI4L&HR2:AJ<VG6SQ6:3,C-&N.0@ 4%B
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M#2*0_E[$5\@#.3D@G&/K6G<>$=^K?VK:ZQ?V5]) MO=2PK"?M"KT9@R$!_<
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MIKNP>.E<K;^#Y8]9T[5[K7+Z\O+)'B#2K&%=& !&%48/&2W4GO@ #J@1CK0
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M^G\DW<ZV\)*,0\C=%R <$^]</+XH_L;PUX0TV#4M/TV2[T^)WN[X9CCC2)>
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M2* &XXHP.V!3L 4!<=: &XXZ]:,9!XI>_6@ $9_6@!.?2C (YS2CCM0!GG-
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MWX1&H6+V9!CMYC$_F!#)O^;YL9&2  /3FO1.?_UT<4 <O)H>I3>+M.UV6:T
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M\4G)[4N,>U(<T '-+FDX'(H/OF@ QZTISBCG'44 9H 4<#D4G)H)QP:4=>*
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M:CVI">>.*7@T !QWQ1WI.W3!I?7B@ )'O29'X4$^U)VZ4  /-&>?:@4N>^*
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MYI'DCBC:61PB*,LS'  ]37G5]-INJ>)YY[*ZO[:%55M1O4NFMHD 7"^A9B
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MKHD4T2:A?722.9,7<HD*D]<' //7Z_4UI@]LB@ QQ0>M*>*.: #IVI,]Z**
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M89(R>O%=5\0>?A_KN>GV.3^56W\)Z&]M;VWV!4BMYOM$8CD=,2_\]"5()?\
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MGSN8\<DCGKFM5_#FF3>&%\/3V_F:<(%@\H,5RJXQRN#VSUH UXPR1JKN68
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M?+N())X)(&>,4:#H<P\1ZKXDO;2*VN[T+!'$C[RL2<;F(X+-@$X[!1VJZ/\
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MP\U5[%61<XZ@GWH ]1(_R*6N!\.Z@UE=>+[Z*&[U#R]1400P$R,R-'&PV G
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MVY"&&"!GVZXM6OC2?4UM;;3M)674Y?/\Z"6Z\N.$0OY;_O A+9;A?EY[XI6
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M/?M323VI<\<B@ S[9I/K2@C(YHSSTH 7C%* ,]*;VX% )SP: '4E)N/>E]*
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M$MHP !/?:7(4^_XT >@"@^M,#@C.<YZ8I0<]: %&,Y_I4<GWXO\ >_H:?G/
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M)>VA@AO[FR8D?OK8)O'M\ZL/TK*'AW4ER/\ A+M<YYP4LS_[;UOD9Z8I1TH
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MT[B@! 2:7FD/'/>D)SZT +DYYH]\T >N: PX[4 &112YSS0 !0 @^M%+BC%
M"#ZTN?6C\** !0,'!S2]12<X'M1Q0 =*,YI*,B@!?PIH^8TN?2D/'- #NE)W
MI&^IS2YZ4 +WHQ2?3]:7K0 F!R:4'W_.FGK1T]#0!G:GS,G'\/\ 6BC4N9T
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M A'7F@4 ?6EQW% #<<T?2C/O1DF@ HZC.<THQWI![T +Q1CG@T=CB@ =\T
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M;#@HW?YCV]S4G!^OI0  YH_E1WS29Q[T .XQTQ2'CM1D8H!/IB@"G?\ WK7
M_P"6R_UJT>!FJM\07M<'_ENO]:MGD4 -Z]LCUHQUI>.E' H 3VIW %!P0*!P
M>GZ4  /.,<4N1THX]:/PH 7%!XI"??-':@!144O#Q8_O?T-2_2HY"-\63_%_
M0TUN)CQS@T>U  H(Q_C2&)U/TI<CUI!TI,<],T .SFDZT D=<TO>@!.#@9I>
M12=Z7J* $PI.1U]*"1C%+V]*#D=J &@$]*7!SR!0!GO2]J #IVS2<^U*?7-
MP.] "_6DX[BC=[4G4"@!<8IN?K2YV^]+P>,4 -ZTHXY-*1G\* H QB@!,'UI
M3CI2<X)S1G'>@!>U)R>E)GWIP!!H 0<#F@#GC&*4C-& /_UT !P.M)CYJ&%
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MR3[\7^]_0TUN)C^>]& >U'/U%'/M2&& *7ZTWZ=:4'F@ R":1O6EX!I />@
M^]_^NE Q1M^OYT#J?6@ YZFC /O2TP'MQB@!0.>F*4]L&DSSCK2D\B@ P<8&
M":,>N:!TY%)CN30 I!["@#'6CD<T9S0 #!%)M]*7C-'.#0 <"CJ>M(<T @4
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MN*3;[TN21VH /8TASCB@'MFE)_R* #M0?848]Z0Y]* #&!FC.>U&/PH'N:
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M.E(V.M /MQ0!0U ?OTYQ\@_F:*-0/^D*,X^0?S-% &EG--X)Y%.[=:;DCTH
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M!XI<Y6@!1C_&DR#1D]*3I0 [!)R#28/2C)QG&*7K0 9QQWI,D'K3N]-.?2@
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M_P"%*10 I]J:<8ZT9 [T'!H IWIYMN_[Y?ZU;["JM\?GM<_\]E_K5D@9SS0
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M1_N#^9HI+W/VKCIL'\S10!H#GJ<>E*:3'TQ0,G&0<4 &.O/YT<?_ *Z*4<T
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M@C-!P?I28P?K2]>E "<= :".101SQ2T 9]Y_Q\\Y^X/YFBEO1_I//]T?S-%
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ME!. * %Q^5'3CL:2E[8(H ">,"DYQBER!VHX//2@ SCK2'KG-+D#J#FD/<T
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MM'(XQ1S0 IZ4W^=+D@=*3-  .PHZ'%(,YZFCJP],4 *2">,TO&*2@\=* "E
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M0 C=.:7C%)@9S2^WZT -/!XH(XR32D<=:!TYH ;_ )ZT#IRU.YZ48_.@!/\
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M*#@^U';FD! S0 [IU-)^-*/SIIYR10 8I0*,4IZ4 ( />E.<<4AR!UHY[-0
M?B:,]L4N *".^: $)SS2=#FE/^>*0>N?PH =P:;GGBEQ2=N<?G0 '@T44F<^
MU "T8S11[4 (,#KUHSWH(S1CWH 7.?6BDZ4=10 < 8H(%(<YHYH  >*/K29]
MORI:  'CIQ1QGI1^0/UI<=,"@!,<\4<=^*7ZFDZC- "_K1^%'?%'&<T )@@\
MTN?P-(3SUI1SS0 AZCO2Y/I1^-+[4 %'3BD[X'\J/QR: %_E2@=:3I2@CM0
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M:!S]:",T +D$#BDR:,&CO[4 &2>F#]*"2!0>G;-(.M %"ZYN3_NC^M%+=_\
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MZ4[!/2DH_6@!/PQ2C..:0G(["C!P.: *-U_Q]-U^Z/ZT47/_ !\MW^4?UHH
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MDX6@ P?6EHSWI#0 <'B@=:6D&:  C-&,=*7%(,_0T &TCMS2'MGK3B#@9I*
M$%  []:4T$XH 3&#TH([TO<4G>@!M+3NW2D YS0 E*,48]Z,#UH ,X/M2GK]
M*3H?6CK0 I/'/\J;@GO2GT%)R#0 IZ8I!^5*1GG%'04 +S^%(1@4N>E(?:@
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MD]J $SS1_.CGKVI,$]#0 4O-%(>G'Z4 +^=% S2?C0 9/I2FDY%*>* $S2T
M<4GY4 +2"C(Z9I<?Y% !^-%)10 HZ]:,Y/-)GL33AC'- !CCUI._-.XQ@4WI
M0 X8Z"DXSWH'3.*3KS0 [-'U%- 'TIV.:  T< T?A1@T -0_(<>IIV.<]J9'
M@*>.YJ3^5  >#BDI>O>D!..E  <=Q2#KFEZT9'3O0!!==8O7S!5A>1S5:YSN
MASC_ %@JSTZT ''?I2=N*.?3BE'?UH *.E'>@#'I0 ZBD)IHS0 [G/%'/>DY
MH&,=Q0 IZ4QN&3MS3LX-(Y&5]S_2@!Q/'%'7@_I1D@4=.E "XSQ1CZ4F?:@?
M2@!:,T@H.2: %!&:7!ZTWBESVH ,=Z*,T=L4 %)CFDZ4I]>M !QG)HZ=*0?4
MT"@ P?:CMBEP?6DQCI0 GTI:3)S1SD<4 !..*/I2GWI .< 4 '!%'>CI0/<4
M '&:._3\:,]J0Y.>.* # ]:/4>M 'KBC\/QH  "*,]\4O49XIO:@ X]*7N,4
M#&*3 Y[4 +G%(231W]:.M !SZ4H/%)WI<#&: %//'>CJ*;3ATZT (!UHY'O3
MLT=: &@Y-*?2D/'/>@<\Y- "$<]:#UH-!]1B@!>.YI/H32\XY%)G\: $S^=&
M?7K1^5!&3R:  X/M2=.]!&*3'0T 4+H?Z2W'8447/_'RW3H** -+!Z8HSMZ\
M"G?YZ4WKTR: #[PZTY>E-/)Z4<G@<8H 4=_6D[C_ !H)..E&<CD=* %'IUI#
MN/M1D9ZX]J<* $ XYH S1GTHY/%  >.E&>.*7'K2Y./\* $!XHX)Z4F0.F*3
MJ<4 .S2"DVX.:7/YT '0TI..:3([#FCDXH !RU+SGK28R!Q1T&0* %)X_P#K
MTAX7K0#S2<4  P>_-*.>IH&<=:!CO0 'BC!/)H/(HR.G:@!!UH-'&/>B@ XQ
MG- Z4=NN#2#- "\'I12# 'TI: $HXQWH[ 49QVH ,YH!/UI,<T[H: $S1TXH
M.>E+0  C%(>GO2]:3J>: %'ZTG?M2G..*.>_Z4 (#ZBG<$<"D/2D(]* ''H*
M3'.#Q1C)XI<$4 +VZ4M)SUI.IX- !GFE[<FC%&* &Q=#UZG^=/Z\5''G;CW-
M/H  3GDTN/<4AZT9'K0 $=?6@8/O29&*4#% %>ZP6A/_ $T%3\CJ:KW0YA_Z
MZ"K&#0 N!WHQTH[4<T +CO133G%* 10 O;I2?C2DT4  Z\YHR,4<C@FEXZ4
M)@'I37X*?7^E. S2. "GU_I0)BYX)S0 "* 1BCD^E Q3CZT9[T8/2D([4 +W
MHSZ9S2$&E/)Z4 )1GG)I/PI10 HZYH_+%)GTZ4'&* %XI/8BCJ./UH H 44=
M!1C/6F]^E #LTF?:D.>U&<#)H 7M[T8'<44A'% "\4G!IO3TQ[4[(XH 0]>*
M.32D>@I!W% "]!S0>0*3!QBC!'UH 48Z4@SS@TN031CK@]: $&>F:4CBDS[X
MI<XXH ;12\X[48Z4 )@GOQ1Q2[01S0<<T )]!QZTN?6D!QZ?C2D\#B@ R* >
M*3CL** %)SCGFC)^M)TZ49QTH "<G-*#CK2<8]Z<,$=* #ZBDQSUH.>M!R10
M F>.:/RHQQFC\: $SCK0<&BC@'&*  ],TASBE[XI"* ,^Z_X^6^@HI;C_CY;
MCL** -'M0>*.V<FC'- "?>I>E(0!SFG#GZ4 -.>QI5QM'/-)WS1CGCI0 I^E
M !^E&,T8QT_.@!V#CDT@ZYI.0><4N<=,9- "DD'BDSG@T<T C- " X[4N?RI
M< T8_&@!,]L4<8P.M)[YI<\]* $HQZ9-.Z^U)_%US0  48]#2GGBDQCI0 O
MZTAP>@Z4AYZT8^7K0 N#Z4F1Z49/K10 O:DHQCOGZT'@X- !UHQ1C/6E(]2*
M #'IUI.?6CF@#\/PH .U'./Z444 '&*;^5+FD)[?RH 4$4ISU'XTW!Q2_A0
M<YHYSS1BC'- "XI<"DI/:@!>E&?2D(S2@<>HH *3@]Z7G%!]_P"= "C&:!FD
M! I1U]* %Z]*7 ]>*:#@^QI2,]Z  8[&E/2D'7BCJ.E #8_NGZG^=/Z\5'%@
M ]>II_XT +CMTINWGO2D4>U  !CIQ0!BE/MQ2'/K0!!=\F'_ *Z"I_QJ"Y^]
M#_UT%6* #I2?6EY[?K0!]<4 '6DQ_.EH[T !-)Q2D8Z4G3@T +FC/'K1[8H(
MH ,Y/ IK?>3ZTXC\:8_WDY[_ -* 9)2'Z49-+D],9H ,X%)0.M ^F* #&?>@
M9HQSWH'/>@!1TX-(<^E+VHYQZ4 )CG!%&WM2X]Z3_@1H 7'O2TGXT8- !GG!
M!%!&1UI,<]>*0>@H .0.E Y/UI2.A[T#@T -(P.M+]:#D]:;Z=: %[FCH.E'
M//-+[=: $SFE[4;:7B@!.U)QGJ:4\]Z3..HYH #P/:DI0<\8I< =J &'FG'
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M"C\:4#;UH[\T )UI.,^YI<XIV.] " __ *Z3'-'THH ,\T 8[4"CC'/\Z #
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M?'+6W_79:MT (>>#P: />CUI>O>@ %!R>":4=>M&>>V* #=]:7&>U(!BES0
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M,\TG!&>E*!Q0 =>F:3WZTOTI,'/7- !VQ1Q1U-+TH ",&C!!XHSG\* <_6@
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M4IQ29% !P#1^ HX/2CC'%  #BE&3R32 X/2DQWQ0 [B@@$?_ %Z3K2X!_I0
M=!P*.@Y/'I2TGMS0 [/;]:;NYZ&C.!ZTO:@!0:".#W-'&*,>E #(/N-V^8_S
MJ0=?:HHC\IQ_?;^=2$YZ$_2@!2<4G3MF@Y^M)UQQB@!<^U-Y_P#KTXC'4T@Z
M]J *E]]ZV&#_ *Y?ZU;'':JM_P#?M3G_ );+_6K1P1Q0 F.<]Z6CGVQ1QVH
M*"<]A1CI2[?>@!<'UH&0.:/J<T?K0 A&32@8ZFC'/2EZGL/QH 3//>F2??B_
MWOZ&G\$]JBDSOC_WOZ&FA,ESBC)^M*#D4=:0Q/TI,$#K2GIC-(2: $('7)-*
MOKG@4G.>E+MQ0 >^:3J>,4N#2C'3% #1P:7&>>E+02#Q0 GXBD/)SS2D9P0*
M0 9.0* %''&*4XQ1VXHQQQ0 W!]..U*3^%!XZT'GGB@ W9'%'7KBD/&>*!0
MXTFWB@YI,]NU "DY..U)SVZ4 ^^*3/.,T +D=**.U-SSTP* '=.]%&,T=N:
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MCD\TG?I2XSTI* $//2@\=J4>](?QH 6DQSUH QW.*4G/>@ R?6DZG-+2 <4
M'U[TH]B:4#B@_I0 N>::1D48!I.AH <!2Y[4@-*>GI0 4?2C\#1^ H 7J<4=
MZ0'VI03CD4 )TX% )-')_P#UTN2.E #(A\I]=Q_G4GXTR'[K?[Q_G3\<YH
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M/:@!<?A2?*.N#0>M&>.* % XI,<T9/<4#Z4 4;G/VJ3\/Y443@?:I./3^5%
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M<].*4&@'T%(8F>U!'M1C'84G6@!1GO0>G6C#8XIISF@ !P>.E+FC;ZT$8Q0
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M/2E)/:@ ZGTI.C8/(H_ T"@ )/\ ^NEXQG%(>#1V[XH .31R/:C!//:D.<4
M+D].:3/-'-!/-  >M)3L G_Z](1QUH 3(QR*4'\*3M10 N,GVI#WHQD&@#'U
MH 0''O2XR<T=Z3KF@ )YZ4OK0>?I01P* $SZ8I>W2@"EQSQ0 @.#CBC)!XZ4
MNWUZTM !WZT8)[4G H!XYH 6E^M-YHSZT *3D\4#K1^/X4?G0 8_&D_2E]L<
M4=Q0 O3/\Z08QTH7&3Q2XSTH 9$!M88_B/\ .I..G>HX?N-_O'^=2 G\/I0
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MM!Z]: *5]C-KSQYZU<'/4]*IWO\ K+7_ *[+_6KO:@ .12<GF@9S_C2DXH
M:,\^U(!U(XI<G'3- "\4E(1SUYI>O44 ':D4DYX_6EQQ0N>E "]ZCD_UD?\
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MC^(_SJ3C/3FHX,;3G^\?YU(.I- !]<_G1GTI<4AH 3D=Z 3UHS2\]Z *=_\
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MW9[4N1Z\TG!H .#WI#U^E'3O24 .!R<4<4@'%'UH 4'M1@'FDX/04N#GKS0
MGOBC/3C\J7.>"*._3\J *%QC[3)^'\A12W'_ !\R?A_(44 :)[X.33>G7&:<
M1GUI#CL?TH ;UX'\Z4>]'7O^%!7//?TH #SR.*3'/7FE/TI!Q0 I8]Z/I1UI
M0<=>E  !]*7G\*0 #FEW"@ /"C&11_.DW#UI<G/- "$9R>:!TX/-+G'7K2<'
MI0 8/3.:4].E)DCC%+].: $SV/Y49'TH)[$4F01SQ0 =:!UHSSQ1_.@ )[&D
MP/PI3D&CJ,<T )@4  4M)CN* %Q[TA^M*/>@@'B@ --YQUH^E!H 7GTI"#ZT
M$YZT$#M0 ?G1Z\<4<B@G- "=NU':E&<=*#QTZ4 *![T=/K248/6@!<XX-&<#
M-)G/I29% #^U-P?:D!S2T !Z4<FCD\=*7I0 =#2T#!%% !Q@44F.: ,>E "Y
MQ2C!Z4' I#G/ YH 7':@<#&*.3S1@]_UH CB'RMZ;C_.I01WJ.+.PG_:/\ZD
M' Z_G0 ,<4A.* *4@=: &G/88HVX.>M*.OM1U:@"G??>M>/^6R]JM_RJI? ;
MK8]_.7^M6^<>U "=!2_7I00"*0<4 +QZ4H('09^M&,XH/IVH !G/-!)SP*,?
MY!I0* $&#03S3J0]/_KT  &/K4<C#?%_O?T-2=JCD)#Q?[W]#36XGL24M'XB
MCO2&(3[4=?QH[<4'IUH  3DCM1WYZTW'>C'( .?K0 'KFEZ=?PI,&C\?SH =
MD&DSZ49('3B@YS0 F.>32@DB@C@4#ITH  ?I1R3G-)F@=:  @CFC.>#1QP!2
MD<\4 (*#S0.O-'2@ XQQ129Y-'?KS0 I_.D. ?\ ZU!].U ]P:  MZ"D!]_R
MIV,"FC@GM0 N?:E/3T^HHX['BB@!>@&:0\TAZ4O- #>.XI?S%+CFB@ !SVHZ
M^E+DFC!% "'B@-CMUI<\=*2@ R>M!^E&/04#DXYH *0TI&._Z4@P* #'MB@X
MZTN!CGBCM_\ 6H 3K28[<9IV/>D&>XH !D=Z.AI?:DH  0<T<#BC%'04 &>?
M:@<CCFDP/6COD'B@"C/G[3)CCD?R%%$__'S)]1_(44 :5(<8[BESCJ:3/MQ0
M @Z\4IXH]\<4=>.E "9Z9I1THZ8&>:49Z 4 -YYS0,BG=3C!H]<T &>@'- ^
M]D_A2]:3 '?-  1T]:3.1@&G=N*0C\* $SDXP*3K3N?6@=>2?I0 W!S[4<]J
M=VX/%&: $Y-+C'6E/MVIO4XS0 8R>.E&,4N.,4$=R!0 WC)S2G[O6C\*#]*
M&]?7-*,]C^=&302<4 )R"1C\:#TH'2E(R.>E #0*4#UI0,].E% "8R>E!Z]*
M#GM1VZT (3E3W- Z>WO2CV)%% "9SVI"<4[ZTC8Z4 (.1TH&>E+GTI,9[4 &
MXCW]Z3.>U+@@=,4=J %'J:0T#IUR:/RH 7'I0.1UH.1WXHS0 H&*7MS2#-+0
M =Z#TI.]&.PH 4D$#BE!XX%-SSTQ2YY.* %4^U'6@<+2<=NOO0 D/W3_ +Q_
MG3\<DU%#G8>?XC_.I10 I.!2=12$\T$GC H 7H*3MP*!]:3/OS0!4OOO6O\
MUV7C\ZN X]:IWQPUM_UV6K><]^*  \FBD.,9Q2T .XQS1@9ZYIN?>EX]* %
M XS^5&?2DZ\_RH!&: %I>!2$_6@$=#S]: %J*3/F1=OF_H:DZ=Z9(#YD6/[W
M]#36XGL/Z]>E  %+2=O:D,3IS_2@Y(Y-+SZYH)H 0'CIFCA?K2@\<C%!P3CK
M0 F>O%&,T=O2@9.: % _*F_3]*7! ZTGT/ZT +R3S2YQTI,_YS29YH 7-(>?
M_K4?SI.>E #AD=J.O-'(P*,]LC\Z $P:,4O)_P#UTF"?2@ YHZ]Z#10 8.>*
M.<\C%';%+D[>U  ?KFD(S[THQ2CKCM0 T#GWI2M+T]Z3G/'!]Z $HY_&EQ@\
MX-)DYQB@  S_ (4I!.#323D'%*#QS0 <YHY/K0!SB@_>YS0 < <T9QUHQ2<B
M@!0210?K1T]<THYXH 3)]128IQ'O^=!&* #@#I2'FC/K02* "DP2:6DZT *3
M@8(H^E("2,YYI._/- "GJ,48YS2\?C10 W\*,$=12]Z7/;- %"7'VF7GN/Y"
MBB;'VJ7ZC^0HH TL=Z3'Y4$]L9I#0 N<<4T^H-+C/'YTH  Q0 GN32Y'K03_
M /JHP3SUH ,CUI:,CZTG4>@H 7/X4<>M)Q@]?RH(.10 N?7\.:3.>V:,#.3]
M.10,B@ ')XH)QQB@#GBE]B* &YI2<=:#GK1F@ )P.: ,\TG?FEZ=* %R,4F<
MT44 !/%)D?Y%*::01F@ -''N:!G'H*0#Z_C0 <YI:3J?I2\4 '.,#BBDQ@TH
MZ\T )SS0.*4X[4N,B@!I'.:,4M% "$4W%.I"0>* $ .<YI>2: ,T$"@!,C\:
M7M1@'H*3&#0 9]J7M1ZT4 %*.!VI">_/YT*010 I..M+D8XIH(ZXH)H =Z<T
MA!QQ1GGI^E.'Z_2@!*4<TG/6@#- "@ Y]?2DX-&TTN"1Z4 1PCY3C'WC_,U*
M>M1P?<;G^(_SIQSTH 4BDQUYI0:7Z4 (!GK1T//(H]128H J7_6UQ_SW7K5L
M=  <U4O>6MO3SUJX<\4 -(/3-+^'YTIZ8(HP>N* $ZT'K3N/:DP"WM0 H]*3
M!)H.?6E4$4 ("0*3\<T['- 4 T  %,E!WQ?[W?Z&I.]12#YX_P#>_H::W$R3
MM2_A29Q_^JE'O2&'2FL.<TO:CDKS0 V@4HXSGK0>>: %R"*3.*3CK_*D[9_G
M0 \'-)CCU- .*.":  ?3([TG':C S1TH 5>M &:!@T$4 )T/&31R?6E^I_2E
MXS0 ''3K28'Y48Q2$YH "P XI V.U+@FCZT -)R>.*=[TG?GCVI: #M2;NW>
MC]* ".YH 7/MS3CC'--'3M2@YH .!TI>,TT>QHH ,9HH_E10 F0: <T4=^E
M"TAZCC%.'':D[T +GGB@>N*0]<TI.: #D]*0D]#0/44?04 %+M-)QZT \G%
M![4>M'MC]*#QQ0 @^E+1G% /O0 4<9Y-&#FD'OVH 7/;-'XTG.<THZT 4)@?
MM4N?4?RHHF_X^9>>X_D** -&D^O6G4TY!'&: $.1T'Y4[/K1D4F10 [\?SI"
M3Z_E2]1G- &,8S0 9.:,^O2EY'4T@R3S0 $^U-Z>^:<>#2#KT/OS0 F:7UH(
MYXI.!P!0 O&.:3MG/%+BDR.G>@ ZGC-!X'?\*4].M)D'Z4 *!@4G?O0#2T '
M [T<^M'3FB@! ><4AX[TH I, =30 H/.30<=:4=*;0 'UQ2=?44N.,@DT'-
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M<]CQ2TG%+[XH #T[&C\Z*.U !0<BCM10 9..N*.O%':B@!.0,4M':@Y'7I0
M8I>*;^-+]#0 8Q1GL12<^N3ZTHX[4 &.3SQ0,F@F@\4 +M-&#C&*3/.*4'@T
M )C'>DZ\4O6@CF@!.G3\J,&@<FCG=P: #-*!DT8S1F@ ^E*/SI._:E .* ,^
M;_CXD^O]!11-Q<R_4?R%% &I24' QGI29%  >^* <&C-("#0 H!QFC ZYH[=
M12'/:@ R,4N>.:3ZG-)G Q0 N:*"1CGO2<9X//O0 X#THQ@9I/QS0#P><>U
M!G)Q1GC- QV-+QWH 3G)&103GD9Q102,]#GVH "1GK2Y'3(I 21F@=?>@ (I
M>U)Z4G/K0 N<_P#UJ..M!'.131_M4 &0:<>G'\Z.,=*,#'K0 T]:7(Q1D>E)
MC(Y H /J#1Q2#B@T '':@4AXZ4O7G/- !FC( ZTGN!2$^E #\@TF<&DY'THS
M^= !D?C29&:7/;%'.* $)I.<\4N._>E ./6@! #ZTI/K2^Q%)T.!Q0 HI,9Z
M=J4<GDT>U !CFC@44$\4 +@]AG\:04HXH(H 3MFG XX-)UIP![T )SGUI1T]
M:0YH[&@".'[IR#G<?YU*03QVJ.(G:WKN/\S4@]/UH 0#GI2_C1^&*3UH ._2
MD(QQ3LCTIIX- %2^QNMC_P!-UJV?7O52]&7M?^NR_P!:N#[O'6@ VDTF".E"
M\=<T$X4G% #AGN:7GMS3 &]:</?M0 8.>M(<9I>^:,#T% !GMP:7H*3CMQ2C
M)Z"@!,YIDF-\?3.[^AJ0G%12'YXL?WOZ&FMQ,DH!!/2@TM(8G6D//K2]!BCL
M*  ?3% ]<TM(.?2@ STHXS12_P">: $^7T%)UZTN"3VI".O% "9Y^E*<D=.:
M3KUZFG8- #1UR?TI>GO1@XH#>M  1@TG-*>QH '_ .J@!,D]*7)Q1WS1G)H
M0GBCZ8I3BFG/M0 I I#CO2TF.>M "XI.O0TO&>** #K[T8R*!UX%*>HS0 @X
MZT''7D4N!FD.#0 44>V*#@XH *#SVS129YQZT +_ "I=P%-QSUH]?6@ ((/M
M1GFC/-+WH !TZ4G'XT'CL* 1GCO0 9YQ1^-+28'6@!?K28]#^M+G--X!YH 4
M  ]:.A&*.@I"1UH =131@^M.H #^% ZTF,TM %";FXE/3YOZ"BB;_CYE^O\
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MH_.BB@!#TXZT#WX% /X4IYX- "9QW)HZ]:.W%&"!TH #TZFC.>]!]#FCMP*
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M'KTI<\]* *=]]^VY.?.7^M6R,54OAA[7_KNO]:MCZ9H ![T444 .%(<GV^E
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MN@#F@!QSBD'J:",T#B@!<C!QFDH)&?NTF<T +031C)ZFCVH 3)S@TM(>#10
M#KUXIW':DH.<]: #O28/8T[&.IS2'CG(_"@!*!R:4\>]&?;F@"E)Q<2_7^E%
M$O\ Q\2?4?RHH T3@G!%-(Q3FQUI!UH 3\J:2>G&*<1[T@/KQ]* $!XI>^2*
M/YT#'3%  .E!&><TIZ<4=L4 )GV_&D//2E YQWH/'>@!0<>])GO1^-'?CI0
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M^7J!^5+0 A!YZT$8[TN:#TH ;R&Y-.XQZTF,FE[]: %]LX%(2!1T]:,97WH
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M>OL* &$8Z4$$=:E[4T@Y]J &XS]* ,?_ %J>!CO1QD4 -Y]*/>G<^E Y[ 4
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M=.E'.* &XP< 9I>O'2CIWYI#GN10 ' HSQ12$>^* %'K1SU-' ' ^E(,_A0
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M_P# <T?\)79?\^U]_P" [4\]:3O0 G_"6V(./LU__P" S4G_  EMB.EO??\
M@,U#=:* %_X2ZP_YX7W_ (#-2?\ "6Z?U,-Z/^W9O\*#36Z?A0 __A+]._YY
M7O\ X"OQ^E'_  E^G#.8[WZ?97_PJ(=J=0 __A+M,/&V\_\  63_  I1XMTS
MTNP/^O23_P")J)NII6Z#ZT 2?\)9I>>!=GZ6DO\ \31_PENE>MW_ . <O_Q-
M0+]X?2GMT/UH E_X2W2<?>NO_ .;_P")H_X2S2/^>EU_X!3?_$5">@^E(.M
M$_\ PEFD?\]+K_P#F_\ B:7_ (2S2#_RUN?_  #F'_LE0-VIIZ'Z4 6/^$LT
MC_GI<_\ @'-_\11_PEFD#_EI=?\ @%-_\14-(W2@"?\ X2O2/^>MS_X!S?\
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M1WH T/\ A(]'_P"@C!_WU1_PD>C?]!*V_P"^Q6=W-)_#0!I#Q%HV/^0E;?\
M?8H/B'1R?^0G;?\ ?P5EGI3NU &D/$6C#_F)VO\ W]%+_P )'HO3^U;/_O\
M+_C65_":@/4T ;@\1Z+_ -!>Q_&X7_&C_A(]$_Z"]C^%PG^-8#=1]*4_UH W
MO^$BT7_H+6/_ ($)_C1_PD6B#_F,6'_@2G^-<\WWA36ZB@#I/^$BT3_H,:?_
M .!*?XTG_"1:+WU?3_\ P)3_ !KF3U%(.C4 =1_PD6B?]!C3_P#P)3_&D_X2
M/0_^@SI__@4G^-<J>E1O]T?6@#K_ /A(-%'/]L6'_@2G^-'_  D.B=?[8L/_
M  )3_&N([_C330!W/_"1:)C_ )#%A_X$I_C0/$&BDX&K6.?^OA/\:X(?>--D
M^[^5 'H']OZ/_P!!6Q_\"$_QH_M_1L?\A:Q_\"$_QKS@]#^%(U 'I U[1V)
MU:Q)'I<)_C2_V[I'_05L3_V\)_C7F+4@[4 >H?VWI)_YBEE_X$)_C1_;6E8_
MY"=G_P!_U_QKRH?>%!Z?A0!ZK_;6DC_F)V?_ '_7_&E_MK2?^@G9_P#?]?\
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<ZB@#W^X<?;)\$?>_I16/HW_(.C_W1_*B@#__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
